Related Experiment Videos
HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy
Insights
Hypertrophic obstructive cardiomyopathy is linked to specific human leukocyte antigen (HLA) genes, particularly HLA-DRW4. This suggests immunogenetic factors may influence the development of this heart condition.
Area of Science:
- Immunogenetics
- Cardiology
- Human Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition with potential genetic underpinnings.
- The role of human leukocyte antigen (HLA) genes in the pathogenesis of HCM remains largely unexplored.
Purpose of the Study:
- To investigate the association between specific HLA gene alleles and the development of hypertrophic cardiomyopathy in a Japanese cohort.
- To determine if distinct HLA profiles differentiate between obstructive and nonobstructive forms of HCM.
Main Methods:
- HLA-A, HLA-B, HLA-C, and HLA-DR specificities were analyzed in 33 Japanese patients diagnosed with HCM.
- Patient groups included 15 with obstructive HCM and 18 with nonobstructive HCM.
- HLA frequencies were compared against a control group of 144 healthy individuals.
Main Results:
- A statistically significant association was observed between HLA-DRW4 and hypertrophic obstructive cardiomyopathy (73% of patients vs. 33% of controls, p < 0.005).
- No significant difference in HLA-DRW4 prevalence was found between patients with hypertrophic nonobstructive cardiomyopathy and controls.
- This study represents the first demonstration of HLA-DR antigen association in hypertrophic cardiomyopathy.
Conclusions:
- The findings suggest that genes within the HLA-DR region are associated with hypertrophic obstructive cardiomyopathy.
- Immunogenetic factors linked to HLA may play a role in the pathogenesis of hypertrophic obstructive cardiomyopathy.
- Further research into the immunogenetic basis of HCM is warranted.
Abstract:
To determine the association of histocompatibility (HLA) genes in patients with hypertrophic cardiomyopathy, we determined HLA-A, HLA-B, HLA-C, and HLA-DR specificities in 33 Japanese patients (15 with the obstructive type off hypertrophic cardiomyopathy, and 18 with the nonobstructive type). HLA-DRW4 was found in 73% of patients with hypertrophic obstructive cardiomyopathy, as compared to 33% of 144 normal controls (p < 0.005). HLA-DRW4 occurred in 33% of those with hypertrophic nonobstructive cardiomyopathy, and there was no significant difference as compared with controls. Thus, hypertrophic obstructive cardiomyopathy is associated with genes in the HLA-DR region and immunogenetic factors linked to HLA appear to play a role in the pathogenesis. This work is the first attempt at demonstration of HLA-DR antigen in hypertrophic cardiomyopathy.